Evolvere BioSciences
YC S24Oxford, GB · Founded 2021 · 3 employees · 1 known investors
Evolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.
AI & Machine LearningBiotechHealthtechAI-powered Drug DiscoveryArtificial IntelligenceTherapeuticsBiotechnologyUnited KingdomEurope
Founders & leadership· Y Combinator alumni (S24)
Evolvere BioSciences was founded in 2021 by Adam Winnifrith, Piotr Jedryszek, and Weronika Slesak.
AW
Adam WinnifrithinFounderAdam Winnifrith holds a degree in biochemistry from Oxford and is CEO and co-founder of Evolvere BioSciences, where he works on bioengineering, protein AI, and automation technologies.
PJ
Piotr JedryszekinFounderPiotr Jedryszek is co-founder and CTO of Evolvere BioSciences, with a background in biology and computational biology.
WS
Weronika SlesakinFounderWeronika Slesak is a biologist educated at Oxford who currently serves as Chief Scientific Officer at Evolvere BioSciences, where she applies evolutionary principles to bioengineering.
Investors · 1
Frequently asked questions
- What does Evolvere BioSciences do?
- Evolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.
- Who founded Evolvere BioSciences?
- Evolvere BioSciences was founded by Adam Winnifrith, Piotr Jedryszek, Weronika Slesak in 2021.
- Who are Evolvere BioSciences's investors?
- Evolvere BioSciences's investors include Y Combinator.
- Where is Evolvere BioSciences headquartered?
- Evolvere BioSciences is headquartered in Oxford, GB.